Disease,chestWallLesions
Disease,cancer
Disease,triple-negativeBreastCancers
Disease,breastCancerDiagnosis
Disease,breastCancers
Disease,breastTumor
Disease,seromaProduction
Disease,CBC
Disease,PA
Disease,breastCancer
Gene,BRCA1
Other,historyOfBreast-conservingSurgery
Other,mayUsed
Other,metastaticDiseaseOnPresentation
contrast,strongContrastWithImagingModalities
Other,formulation
Other,femaleSibling
Other,patientsWithLabc
Other,brca1Wild-typeTnbcCells
Other,results
Other,themselves
Other,greater
Other,effectiveDiagnosisOfBreastCancer
Other,fiveDoses
Other,modifiedFactor
prognostic,strongIndependentPrognosticFactor
Other,screening
Other,humanErrors
Other,developed
Other,presenceOfMetastaticDiseaseAtPresentation
Other,familyHistory
Other,established
Other,mostSensitiveTestForBreastCancerDetection
Other,complex
Other,strongFamilyHistoryOfCancer
Other,measured
Other,23Studies
signal,additionalIndicator
Other,visuallyDetectable
Other,accomplished
performance,diagnosticPerformanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
Other,lungCancerInHuman
Other,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
Other,ourExperience
Other,familyImpact
Other,387Percecnt
Other,veryComplexDisease
Other,previousStudies
Other,meta-analysis
Other,malign
Other,lowDiagnosticSensitivityForWomenWithDenseBreasts
contrast,therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments
Other,amount
signal,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
vitro,infraredFluorescentImagingInTripleNegativeInVitro
Other,variableMolecularMechanismsOfCarcinogenesis
performance,performance
Other,theirBeliefsRegardingCancerCausation
contrast,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,test
Other,correspondingCohort
Other,brca1Levels
protocols,abbreviatedMriProtocols
Other,mostCommonCancer
Other,second
Other,hasFound
Other,diet
Other,fiveDosesOfAdjuvantTranstuzumab
Other,howeverUnderutilized
membrane,glycosylationOfMembraneTypeMr
Other,therapeuticBenefits
Other,enhancementOfImage
Other,recognized
Other,cxcr4ExpressionDeterminedByImmunohistochemistry
Other,potential
Other,outcomeOverCosts
Other,recorded
Other,theirOriginallyTargetedPopulationsOfBreastCancer
Other,tnbcCells
contrast,issuesOfExistingContrastAgents
Other,apoptosis
Other,agents
Other,implemented
aspirin,associationBetweenPost-diagnosisLow-doseAspirinUse
intake,associationBetweenIntakeOfB-carotene
PET,recentlyIntroducedCxcr4-targetedPetProbe68ga-pentixafor
Other,analyzed
cases,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
components,specificCancerCell-relatedComponents
Other,imaging
Other,issues
anti-HER2,additionalAnti-her2Therapy
Other,outcomesOfEstrogenReceptorPositive
Other,invasiveBreastCancer
Other,detectionOfBreastCancerInWomen
Other,NAC
Other,found
Other,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
Other,brcanessPhenotypeInBrca1Wild-typeTnbcCells
Other,protected
Other,multipleFactors
contrast,differentContrastAgent
Other,widerPopulationOfTnbcPatients
Other,updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
Other,theirExperiencesLivingWithSister
Other,previousBreast/axillarySurgery
cases,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,images
Other,randomEffectsModel
Other,familyMember
Other,familyMemberAffectedWithCancer
Other,life
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,neuralNetworkClassifier
Other,total
contrast,evidencedByIncreaseInContrastAfterInjection
Other,comparedSemi-quantitatively
Other,mustAddressed
Other,asResultAreUsed
Other,estimated
Other,dnaDamage
Other,responsible
Other,brca1Wild-typeTripleNegativeBreastCancer
BRD4,brd4Regulation
Other,cellCycleRegulators
IORT,IORT
Other,betterOutcomeWithGoodNegativePredictiveValue
Other,alsoShaped
Other,treatment
Other,due
Other,useOfAdvancedImagingExaminations
Other,evaluatedInVivo
cases,allFiveCases
Other,managementOfTumour-relatedSymptoms
intake,summaryHazardRatioOf070ForHighestIntake
Other,825Ml
Other,radiotherapy
Other,intravenousAdministrationOfOsteopontin-750Probe
Other,formulationOfEffectiveManagementPlanForAt-riskWomen
Other,understand
18F-FDG,18f-fdgPet
Other,haveDeveloped
Other,notablyDesigned
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,performed
Other,consistent
Other,rare
Other,mostInvasiveDisease
Other,25Months
Other,sensitive
Other,amongThemNewlyIdentifiedInStudy
Other,majorConcerns
prognostic,subtype-specificPrognosticSignatures
Other,diagnosisOfResponseToTreatment
Other,diagnosed
Other,highlyExpressed
Other,largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
case,case
Other,largelyConsistent
Other,60Years
Other,misdiagnosis
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Other,involvedInDnaDamageRegulation
Other,included
Other,combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
Other,preciseToolForTargetedTreatmentOfCancerIncludingBc
Other,firstDiagnosisOfBreastCancer
Other,patientsWithProlactinoma
Other,particular
Other,familialCancerClusteringInPatientsWithProlactinoma
aspirin,time-varyingPost-diagnosisLow-doseAspirinUse
Other,thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
Other,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,areUsed
protocols,overviewOfAbbreviatedBreastMriProtocols
Other,unusual
Other,performedFromInceptionToJanuary312018
Other,discussed
Other,missed
Other,breastCancerPatientsSerum
Other,patient'sOutcomeOverCosts
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,riskStratification
aspirin,aspirinUse
Other,non-ideal
Other,denseBreasts
cases,only35CasesOfTraumaticBreastNeuromas
Other,haveReportedMainlyAfterMastectomy
aspirin,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,needed
Other,used
Other,newValue-basedHealthcareParadigm
Other,areInvestigated
Other,x-rayMammography
Other,itsWidespreadUse
lesion,mayIndicativeOfBenignLesion
Other,stageIiiBreastCaner
Other,required
Other,inLongTermHasFound
Other,present
Other,unresectedLocallyAdvancedBreastCancer
Other,glycosylation
vitro,bindingToBreastCancerCellsInVitro
Other,itsUse
HER2,elderlyPatientWithRelapsedHer2
excision,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
Other,reported
Other,haveReported
Other,moreDirectional
intake,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,applied
cTn,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,harmfulorHarmlessTissues
Other,imagingModalities
Other,ourExperienceOfHigh-doseRadiotherapy
vitro,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Other,68Ga-Pentixafor
contrast,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,56Percecnt
Other,necessity
Other,feasible
Other,shaped
Other,combination
Other,soFarHasMainlyAssociatedWithMutationsInBrca1
signal,indicator
Other,mutationalStatusBesidesFamilyHistory
Other,thematicAnalysis
Other,primaryBreastCancerPatientsTreatedBetween01012010
Other,ageOf25Years
Other,fourTypesOfBreastCancer
Other,hasApplied
Other,nationwideRegistries
MSOT,MSOT
Other,amountOfObservedVariationInSeromaProduction
Other,diagnosisOfAcuteCoronarySyndromes
Other,relativesOfPatientsWithPa
accumulation,trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology
Other,confirmed
Other,risk
Other,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Other,mostSensitiveTest
Other,value
signatures,signatures
Other,significantlyHigherThanInFamiliesOfNfpaPatients
Other,375Percecnt
Other,related
Other,outpatientClinic
Other,sixGlycosylationSites
Other,concerns
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Other,necessary
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,howeverNon-ideal
Other,urgentlyNeeded
Other,higher
Other,transferable
Other,targetedImmuneCell
Other,advancedDiagnosticImaging
Other,expressed
protocols,mriProtocols
Other,osteopontinPeptide
Other,imagingInvestigations
Other,patientsWithHistoryOfBreastSurgery
Other,patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
fluorescent,infraredFluorescentDye
Other,haveIntroduced
Other,tumorImaging
Other,woundDrainsPlacedInBreast
Other,massSpectrometry
Other,identified
Other,diagnosis
Other,inconsistentResults
Other,54Percecnt
Other,lapatinibCombined
Other,generallyReserved
Other,mostEffectiveTechniqueused
Other,similar
Other,overview
Other,thereforeHasAppliedToEarlyIdentification
Other,factor
case,veryRareCaseOfTraumaticBreastNeuroma
Other,oneYear
Other,mayUsedForTumourShrinkagePriorToSurgery
Other,developedCbcDuring
performance,course
Other,hasInconsistent
Other,stratified
Other,heterogeneousCancerInFemalePatientsWorldwide
Other,use
binding,binding
Other,update
MRI,costOfMriExamination
Other,involved
performance,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,moreRecentlyHaveDeveloped
Other,mustAddressedDuringCancerGeneticCounselingConsultations
Other,reduction
Other,decreasesInBcMortalityRates
Other,dose-dependentReductionInBrca1Levels
Other,preclinicalPhase
Other,currentUsersOfLongerDuration
anti-HER2,neoadjuvantAnti-her2Treatment
contrast,contrastAfterInjection
Other,compared
Other,howeverSignificantlyLower
Other,reportedInSignificantlyHigherProportionOfPatientsWithPa
Other,strong
Other,processing
Other,moreCommonlyDiagnosed
HER2,aggressiveCourseOfHer2Cancer
Other,bcMortalityRates
Other,brcanessPhenotype
Other,decades
Other,management
Other,high-resolutionImages
Other,designed
cases,only35Cases
Other,copyright
Other,itsMinimalSilverIonReleaseProfiles
Other,25MonthsFromDiagnosis
Other,mostCommonAgentsUsedInBreastCancerTreatment
Species,patients
Species,women
Species,nudeMice
Species,human
Species,patient
Disease,lungCancer
Disease,cancer
Disease,breastCancerDiagnosis
Disease,lungCancer
Disease,acromegaly
Disease,colorectalCancer
Disease,seromaProduction
Disease,breastCancer
Disease,breastCancer
Disease,breastCancer
Disease,AION
Disease,TNBC
Gene,CXCR4
Other,She
Other,youngPatients
Other,screeningBehavior
excision,excision
Other,filipinoWomen
Other,novelTargetedTherapeuticOptions
Other,results
Other,BACKGROUND
18F-FDG,18f-fdgPet/ctImages
Other,hormonalContraceptionUse
intake,intake
Other,longScanTime
Other,tumorDetectability
components,components
Other,theirEmergingRole
Other,we
contrast,contrastAgents
Other,cohortStudy
Other,agreement
Other,third-degree
Other,smallMoleculeInhibitors
Other,95PercecntConfidenceIntervals
Other,theResulting
Other,Metastases
Other,Anthracyclines
Other,12-15Percecnt
Other,Aims
Other,amount
Other,analysis
accumulation,osteopontin-750Accumulation
PET,cxcr4-targetedPetImaging
MRI,unenhancedMriTechniques
Other,osteopontin-basedProbe
Other,healthcarePolicyMakers
Other,seromaFormation
Other,article
Other,betterUnderstanding
cTn,ctnLevels
Other,relationship
Other,moreSpecificApplications
Other,homologousRecombinationPathway
Other,signature
Other,dose-dependentReduction
models,coxProportionalHazardRegressionModels
Other,cancerRiskPerception
Other,initialResults
Other,doses
Other,466Percecnt
Other,ourFindings
Other,probe
Other,Information
Other,tumor-to-backgroundRatios
Other,theirAbility
Other,radicalSurgicalApproaches
Other,differentialDiagnosis
Other,percecntConfidenceIntervals
Other,recentDanishCohortStudy
Other,imagingTechnique
Other,medianAmount
cases,24ApplicableCases
Other,breastImagingModality
Other,tenStudies
Other,manyFeatures
Other,They
cTn,lowCtnLevels
Other,evaluation
Other,importantCornerstone
Other,summaryHazardRatios
Other,comprehensiveSearch
Other,highIndex
Other,significantAdvances
excision,surgicalExcision
Other,she
Other,Ulceration
Other,similarTowaveletFilter
Other,they
Other,We
Other,increase
cases,forty-threeCases
Other,postmenopausalPatient
BRD4,brd4Regulation
Other,disease
IORT,IORT
Other,biomarker
membrane,membraneTypeMr
Other,understanding
Other,treatment
Other,discovery
Other,percecnt
Other,options
Other,multiresolutionResult
Other,Mammography
Other,contraceptionUse
Other,locoregionalRadiotherapy
Other,role
Other,RESULTS
Other,radiotherapy
membrane,membraneTypeMannoseReceptor
Other,identification
Other,novelPowerfulTechnique
signatures,collectedSignatures
Other,cornerstone
Other,observationalStudies
Other,troponins
Other,mutations
MRI,MRI
Other,differentStudies
Other,femalePatients
accumulation,strongAssociation
Other,five
case,case
lesion,lesion
Other,12SampledWomen
Other,furtherDevelopment
Other,studies
Other,neuroma
Other,I2
Other,it
Other,[]anti-her2Therapies
Other,herPresentation
Other,directRelationship
Other,screeningTools
Other,Comparison
anti-HER2,anti-her2Therapy
Other,Efforts
Other,cardiacTroponins
Other,medianFollow-up
Other,herDisease
Other,mammographicImages
accumulation,association
Other,alternativeContrast-enhancedScreeningTools
Other,theirInhibition
Other,medianAge
Other,study
Other,time
performance,diagnosticPerformance
Other,research
MRI,mriTechniques
Other,aim
Other,the
Other,familialCancerClustering
Other,most
cases,24Cases
Other,subcutaneousBreastTumor
Other,anti-her2Therapies
Other,necessity
Other,decreases
Other,improvedDetection
Other,currentDevelopments
Other,diagnosticEvaluation
contrast,strongContrast
Other,fluorescenceImagingExVivo
Other,markedReduction
Other,ourLiteratureReview
Other,respondents
Other,standardizedImagingProtocol
Other,risk
Other,barcodeMode
Other,traumaticNeuroma
prognostic,numerousGene-expression-basedPrognosticSignatures
Other,clinicians
neuromas,traumaticBreastNeuromas
Other,follow-up
signatures,signatures
Other,subtype-specificSignature
MSOT,msotImaging
neuromas,breastNeuromas
Other,higher
Other,features
cardiotoxicities,theirCardiotoxicities
protocols,mriProtocols
Other,development
contrast,availableContrastAgents
Other,improvedBreastCancerOs
cases,cases
Other,1
Other,detection
models,coxHazardRegressionModels
Other,repair
binding,selectiveBinding
Other,use
signal,signalIntensity
Other,subjectiveRisk
binding,binding
Other,involved
Other,conventionalX-rayMammography
BRD4,brd4PharmacologicalInhibition
Other,higherSuvmax
PET,petImaging
Other,Breast
Other,adjustment
Other,furtherResearch
Other,breast
Other,detectionofBreastCancer
Other,brcanessPhenotype
Other,Transcripts
Other,higherResolution
Other,age
Other,patientDemographics
Other,prolongedRecovery
Other,experiences
Other,segmentationAlgorithm
Other,metastaticDisease
BRD4,brd4Inhibition
cTn,cTn
Other,pharmacologicalInduction
Other,conservativeTreatment
Other,observedVariation
Other,clinicalBreastExamination
Species,patients
Species,Patients
Species,women
Species,People
Species,patient